Fabrazyme Alternatives Compared
| Fabrazyme (agalsidase beta) | Galafold (migalastat) | Agalsidase beta |
|
|---|
| Fabrazyme (agalsidase beta) | Galafold (migalastat) | Agalsidase beta |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Fabry Disease. Fabrazyme may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Fabry Disease. Galafold may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Fabry Disease. Agalsidase beta may also be used for purposes not listed in this medication guide. |
Related suggestions Fabry Disease
|
|||||||||||||||
| More about Fabrazyme (agalsidase beta) | More about Galafold (migalastat) | More about Agalsidase beta | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Fabrazyme side effects |
View all Galafold side effects |
View all Agalsidase beta side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Fabrazyme prices |
View all Galafold prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Fabrazyme | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
1.7 hours |
5 hours |
1.7 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 5 drugs are known to interact with Fabrazyme:
|
A total of 1 drugs are known to interact with Galafold:
|
A total of 5 drugs are known to interact with Agalsidase beta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
April 24, 2003 |
August 10, 2018 |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Elfabrio
Elfabrio (pegunigalsidase alfa-iwxj) is an enzyme replacement treatment that may be used long-term ...
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.